Galderma will share exciting results from the Sculptra® Cheek Wrinkle study showing the long-lasting effectiveness and safety of Sculptra, as well as high aesthetic improvement and patient satisfactio
The 2023 American Academy of Dermatology (AAD) Annual Meeting will see the data premiere of the phase III OLYMPIA 2 trial, where nemolizumab monotherapy met all primary and key secondary endpoints and
The Sensitive Skincare Faculty is a first-of-its-kind global community of experts dedicated to creating a better life for people with sensitive skin The Sensitive Skincare Faculty will focus on three
Galderma, the pure-play dermatology category leader with a 40+ year heritage in dermatology, will present one oral, six symposia and four hub sessions demonstrating its scientific expertise and ongoin
/newsonfloor/media/post_banners/gjlUKdiix5eAjL4D56Zl.jpg)
/newsonfloor/media/post_banners/r4mwwnA3gHquLu9vUqP6.jpg)
/newsonfloor/media/post_banners/bq6Y7074JQRLMZQYioVN.jpg)
/newsonfloor/media/post_banners/kHhKCQ99DBtauyMPfBFG.jpg)
/newsonfloor/media/post_banners/N0UvMXVSr1kVsp23pQG3.jpg)
